EPS is commonly considered to be one of the most important factors when evaluating the price of a share. Taking a look at the current quarter consensus earnings per share estimate provided by Zacks Research, we can see that the number for CONMED Corporation (NASDAQ:CNMD) is 0.73. This estimate is using projections provided by 3 Wall Street analysts. Last quarter, the company notched a quarterly EPS of 0.46. Trading around earnings reports can be difficult. Gauging which direction a stock will shift after earnings can sometimes be a toss up. Sometimes, companies may report great numbers with a solid beat, and the stock will head lower. Other times, a stock will miss projections, but the price will rise. Traders who are able to take on the risk may be able to withstand the high volatility that could follow after the report is released.
Investors may be searching high and low in the market to find some bargain stocks to add to the portfolio. Finding those great stocks at cheap prices may take a lot of research and dedication. Many investors will opt to compare stocks in the same industry. This may be a good way to help determine which ones are poised to stand out above the rest. As we move into the second half of the year, all eyes will be watching the major economic reports. If the data continues to impress, the stock market may continue to cruise along without many hiccups. Careful investors will no doubt be combing through specific company data to make sure the fundamentals are in line as well. Following company fundamentals and stock technicals may help create a wider frame of reference to work with.
Sell-side Street analysts often offer stock ratings for companies that they cover. Based on analysts polled by Zacks Research, the present average broker rating on shares of CONMED Corporation (NASDAQ:CNMD) is presently 2.8. This average rating includes analysts who have given Sell, Buy and Hold ratings on the equity. This rating uses a numerical recommendation scale from 1 to 5. A score of 1 would represent a Buy recommendation, and a score of 5 would indicate a Sell recommendation. Out of all the analysts providing recommendations, 1 have rated the stock a Strong Buy or Buy, based on data provided by Zacks Research.
Taking a look at some target price information, we note that shares of CONMED Corporation (NASDAQ:CNMD) presently have an average target price of $79.25. This is the consensus target price using estimates offered by analysts polled by Zacks Research. Sell-side analysts can calculate price target projections using various methods. Many investors will track stock target prices, especially when analysts make changes to the target. A thorough research report will generally give detailed reasoning for a certain target projection. Some investors may watch sell-side targets very closely and use the data to help with their own stock research.
Let’s shift the focus and look at some historical stock price action on shares of CONMED Corporation (NASDAQ:CNMD). After a recent market scan, we have seen that the stock has been trading near the $68.33 level. Investors may also be tracking the current stock price in relation to its 52-week high and low. The 52-week high is currently sitting at $81.64, and the 52-week low is $49.3. When the stock starts moving towards the 52-week high or 52-week low, investors may pay added attention to see if there will be a breakthrough that level. Over the last 12 weeks, the stock has moved -12.26%. Since the beginning of the calendar year, we can see that shares have changed 34.06%. Over the past 4 weeks, shares have moved -6.75%. Over the previous 5 sessions, the stock has moved -1.31%.
There are many factors that may influence stock price action. One of the most influential factors is company earnings. Company earnings reports can be extremely important for investors. Earnings reports have the ability to let investors know how well or poorly a company has been performing. Investors may try to capitalize on trading around earnings announcements. This can be a very tricky venture and may be quite risky. Studying stock price movements around earnings reports can sometimes be confusing. Often times a company will post better than expected numbers but the stock will drop in price. On the other side, shares may see a bounce even after disappointing results. Analysts try to project what numbers the company will post, but they may not be accurate for a variety of reasons. Following analyst estimates around earnings reports may be helpful, but it may be wise to proceed with caution if only going on what the analysts are saying.